Molecular Analysis of Myeloid/lymphoid or Mixedlineage Leukemia (MLL) Gene Rearrangement in Acute Myelogenous Leukemia with Normal Cytogenetics
碩士 === 國立中山大學 === 生物科學系研究所 === 100 === Acute myeloid leukemia (AML) is a highly heterogeneous disorder that results from a block in the differentiation of hematopoietic progenitor cells along with uncontrolled proliferation. In approximately 60% of cases, specific recurrent chromosomal aberrations c...
Main Authors: | , |
---|---|
Other Authors: | |
Format: | Others |
Language: | zh-TW |
Published: |
2012
|
Online Access: | http://ndltd.ncl.edu.tw/handle/20646156786695208611 |
id |
ndltd-TW-100NSYS5112018 |
---|---|
record_format |
oai_dc |
spelling |
ndltd-TW-100NSYS51120182015-10-13T21:22:19Z http://ndltd.ncl.edu.tw/handle/20646156786695208611 Molecular Analysis of Myeloid/lymphoid or Mixedlineage Leukemia (MLL) Gene Rearrangement in Acute Myelogenous Leukemia with Normal Cytogenetics 染色體核型正常之急性骨髓性白血病其MLL基因轉位之分子檢驗 Ya-Lan Chen 陳雅蘭 碩士 國立中山大學 生物科學系研究所 100 Acute myeloid leukemia (AML) is a highly heterogeneous disorder that results from a block in the differentiation of hematopoietic progenitor cells along with uncontrolled proliferation. In approximately 60% of cases, specific recurrent chromosomal aberrations can be identified by modern cytogenetic techniques, and is an important indicator to classify patients into three prognostic categories: favorable, intermediate, and poor risk. Currently, favorable risk patients are usually treated with chemotherapy while poor risk patients receive allogeneic stem cell transplantation. However, the largest subgroup of AML patients (approximately 40%) has no identifiable cytogenetic abnormalities and is classified as intermediate risk. In this special subgroup of patients, a number of studies have demonstrated the relationship between different translocations involving the mixed lineage leukemia (MLL) gene and patient prognosis. The heterogeneity of MLL-rearranged AML is reflected by the identification of more than 70 different fusion partners of this gene and the panel is continuously increasing. The aim of this study is to develop a sensitive molecular profiling test for relevant risk stratification that can help in the decision of treatment and/or follow-up strategy. Ming-Hong Tai 戴明泓 2012 學位論文 ; thesis 98 zh-TW |
collection |
NDLTD |
language |
zh-TW |
format |
Others
|
sources |
NDLTD |
description |
碩士 === 國立中山大學 === 生物科學系研究所 === 100 === Acute myeloid leukemia (AML) is a highly heterogeneous disorder that results from a block in the differentiation of hematopoietic progenitor cells along with uncontrolled proliferation. In approximately 60% of cases, specific recurrent chromosomal
aberrations can be identified by modern cytogenetic techniques, and is an important indicator to classify patients into three prognostic categories: favorable, intermediate, and poor risk. Currently, favorable risk patients are usually treated with chemotherapy while poor risk patients receive allogeneic stem cell transplantation. However, the largest subgroup of AML patients (approximately 40%) has no identifiable cytogenetic abnormalities and is classified as intermediate risk. In this special subgroup of patients, a number of studies have demonstrated the relationship between different translocations involving the mixed lineage leukemia (MLL) gene and patient
prognosis. The heterogeneity of MLL-rearranged AML is reflected by the identification of more than 70 different fusion partners of this gene and the panel is continuously increasing. The aim of this study is to develop a sensitive molecular profiling test for relevant risk stratification that can help in the decision of treatment and/or follow-up strategy.
|
author2 |
Ming-Hong Tai |
author_facet |
Ming-Hong Tai Ya-Lan Chen 陳雅蘭 |
author |
Ya-Lan Chen 陳雅蘭 |
spellingShingle |
Ya-Lan Chen 陳雅蘭 Molecular Analysis of Myeloid/lymphoid or Mixedlineage Leukemia (MLL) Gene Rearrangement in Acute Myelogenous Leukemia with Normal Cytogenetics |
author_sort |
Ya-Lan Chen |
title |
Molecular Analysis of Myeloid/lymphoid or Mixedlineage Leukemia (MLL) Gene Rearrangement in Acute Myelogenous Leukemia with Normal Cytogenetics |
title_short |
Molecular Analysis of Myeloid/lymphoid or Mixedlineage Leukemia (MLL) Gene Rearrangement in Acute Myelogenous Leukemia with Normal Cytogenetics |
title_full |
Molecular Analysis of Myeloid/lymphoid or Mixedlineage Leukemia (MLL) Gene Rearrangement in Acute Myelogenous Leukemia with Normal Cytogenetics |
title_fullStr |
Molecular Analysis of Myeloid/lymphoid or Mixedlineage Leukemia (MLL) Gene Rearrangement in Acute Myelogenous Leukemia with Normal Cytogenetics |
title_full_unstemmed |
Molecular Analysis of Myeloid/lymphoid or Mixedlineage Leukemia (MLL) Gene Rearrangement in Acute Myelogenous Leukemia with Normal Cytogenetics |
title_sort |
molecular analysis of myeloid/lymphoid or mixedlineage leukemia (mll) gene rearrangement in acute myelogenous leukemia with normal cytogenetics |
publishDate |
2012 |
url |
http://ndltd.ncl.edu.tw/handle/20646156786695208611 |
work_keys_str_mv |
AT yalanchen molecularanalysisofmyeloidlymphoidormixedlineageleukemiamllgenerearrangementinacutemyelogenousleukemiawithnormalcytogenetics AT chényǎlán molecularanalysisofmyeloidlymphoidormixedlineageleukemiamllgenerearrangementinacutemyelogenousleukemiawithnormalcytogenetics AT yalanchen rǎnsètǐhéxíngzhèngchángzhījíxìnggǔsuǐxìngbáixuèbìngqímlljīyīnzhuǎnwèizhīfēnzijiǎnyàn AT chényǎlán rǎnsètǐhéxíngzhèngchángzhījíxìnggǔsuǐxìngbáixuèbìngqímlljīyīnzhuǎnwèizhīfēnzijiǎnyàn |
_version_ |
1718060230199214080 |